| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.0094 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |